Bentham Science is pleased to announce that Current Radiopharmaceuticals is now indexed in Science Citation Index Expanded (Pharmacology & Pharmacy; Radiology, Nuclear Medicine & Medical Imaging) for the year 2021, onwards. Bentham Science would like to congratulate all scholarly contributors involved with the journal.

Since its inception in 2008, Current Radiopharmaceuticals has been communicating information about research and developments about radiolabeled compound preparations used for studies in nuclear medicine, molecular imaging, radionuclide therapy, and basic research in natural sciences. The journal is of interest to readers interested in advances in radio imaging techniques, therapies; preparation and application of radionuclide compounds including the incorporation of tracer methods used in scientific research, and medical applications (radiology, oncology and radiotherapy). Current Radiopharmaceuticals will continue to deliver impactful research in the field to readers around the world and we look forward to seeing the journal gain recognition among the top journals in the respective fields in the time ahead.

Learn more about the journal here: https://www.eurekaselect.com/journal/95

Science Citation Index Expanded™ (Powered by Clarivate) indexes over 9,200 of the world’s most impactful journals across 178 scientific disciplines. Clarivate’s expert in-house editors select the most influential journals in their respective fields according to a set of 28 criteria that help them determine scholarly quality and impact.